Develops plant-derived ingredients for various industries. Produces plant-derived ingredients. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Red columns mark years that ended in a loss.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
An investor who bought at the very peak is down 83% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $19.8M in the vault; even if every debt were paid off, $19.8M would remain.
A loss of $1.9M against $0 in annual sales. And on top of that, sales fell from the year before.
The stock sits at $0.08. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
This stock swings about 4.7 times as much as the market average. Big rallies — and big drops — can both happen fast.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.